Dexmedetomidine (Dex) demonstrates neuroprotective properties by modulating the HIF-1α pathway, as evidenced by its ability to reduce neuronal apoptosis and ameliorate cerebral ischemia-reperfusion injury in animal models. The gene discussed is HIF1A; the disease is brain ischemia.